ONCrg Pipeline Strategies
Competitive Landscapes

Why We Make a Difference

Build + Elevate = Best-In-Class
ONCrg Product Pyramid

Because each ONCrg Pipeline Strategies cancer area report is carefully built, product by product, trial by trial, by a dedicated CI expert in an exhaustive analysis of scientific, clinical and commercial factors, we elevate your vantage point over the treatment landscape for an unparalleled view of competition and opportunities in your drug market of interest.

Our Presentation and Compendium reports are considered best-in-class, not only because they contain a wealth of practical insight but also because they are updated quarterly with new data from conferences, our sentinel surveillance, and other sources.

ONCrg Pipeline Strategies™LandscapesProfilesCompendiumUpdates
ONCrg Pipeline Strategies
reports provide comprehensive, cancer specific analyses of treatment landscapes for drugs in Ph I/II development and beyond. These resources include a presentation style PPT deck and a detailed PDF compendium which are refreshed quarterly to retain their accuracy and relevance.
Treatment Landscapes:
Each cancer area is described by the framework that best fits the specific cancer market, whether that is by patient subtype, molecular biomarkers, treatment stage and drug class and include visual analytics such as treatment algorithms, benchmarks, registrational trials, and key clinical criteria and guidelines to provide a big picture orientation of how new products may fit into the market landscape.
Product Profiles:
In each cancer area, products in Ph I/II development and beyond are evaluated by class and subclass, and summary slides are provided for each agent including clinical status by region, commercial rights, MOA/ROA, likely scenarios of use (patient subsets), SWOT analysis, milestones (upcoming and last) and clinical trial timelines.
Compendiums:
These cancer area reports take Product Profiles one step further by providing a comprehensive analysis and history of a drug's development and the details of clinical trials completed and in progress, including trial results when available.
Updates:
On a quarterly basis, ONCrg Pipeline Strategies reports are updated with relevant scientific, clinical and commercial developments. ONCrg disease area experts vigilantly monitor multiple secondary and primary sources including peer-reviewed literature, conference news, SEC filings, press releases, and electronic databases such as Adis R&D Insight, ClinicalTrials.gov.

Oncology Coverage

Click your area of interest for a Sample of our Pipeline Strategies report
Solid Tumors
GI - Gastrointestinal GU - Genitourinary Women’s Cancer Lung Other
Colorectal Bladder Breast NSCLC Gliomas
Esophageal Prostate Endometrial SCLC H&N
Gastric RCC Ovarian   Melanoma
HCC       STS
Pancreatic        
         
Immuno-Oncology
MOAs
Hematologic Malignancies
IO Emerging Cell Therapies ALL MDS MPNs
IO Late Stage   AML MM NHL
    CLL    

Don’t Take Our Word For It

    Information and Sample Requests
    To learn more about our reports, services, and CI support, please fill out the form below or call us at 650.485.2626.
    *Please note, we will not share your details outside of our company

    Continue to Colorectal page
    or
    Request Sample Report

    Continue to Bladder page
    or
    Request Sample Report

    Continue to Breast page
    or
    Request Sample Report

    Continue to NSCLC page
    or
    Request Sample Report

    Continue to Gliomas page
    or
    Request Sample Report

    Continue to Esophageal page
    or
    Request Sample Report

    Continue to Prostate page
    or
    Request Sample Report

    Continue to Endometrial page
    or
    Request Sample Report

    Continue to SCLC page
    or
    Request Sample Report

    Continue to H&N page
    or
    Request Sample Report

    Continue to Gastric page
    or
    Request Sample Report

    Continue to RCC page
    or
    Request Sample Report

    Continue to Ovarian page
    or
    Request Sample Report

    Continue to Melanoma page
    or
    Request Sample Report

    Continue to HCC page
    or
    Request Sample Report

    Continue to STS page
    or
    Request Sample Report

    Continue to Pancreatic page
    or
    Request Sample Report

    Continue to IO Emerging page
    or
    Request Sample Report

    Continue to Cell Therapies page
    or
    Request Sample Report

    Continue to ALL page
    or
    Request Sample Report

    Continue to MDS page
    or
    Request Sample Report

    Continue to MPNs page
    or
    Request Sample Report

    Continue to IO Late Stage page
    or
    Request Sample Report

    Continue to AML page
    or
    Request Sample Report

    Continue to MM page
    or
    Request Sample Report

    Continue to NHL page
    or
    Request Sample Report

    Continue to CLL page
    or
    Request Sample Report